← Eichor
Condition: Guselkumab Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Guselkumab

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · 85 location(s) · Janssen Research & Development, LLC · NCT05923073Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)
Phase N/A · 12 location(s) · TIDHI Innovation Inc. · NCT07245394Guselkumab Vs Ustekinumab in Stricturing Crohn's Disease
Phase N/A · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07444060Ultrasound and Proteomics for Guselkumab Response Assessment in Crohn's Disease (UPGRADE).
Phase N/A · 1 location(s) · University of Calgary · NCT07246460Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
Phase 3 · 14 location(s) · University of Pennsylvania · NCT05669833A Study of Guselkumab Treatment Persistence in Psoriatic Arthritis Participants
Phase N/A · 1 location(s) · Janssen-Cilag Ltd. · NCT07532226IUS Predicts Guselkumab Efficacy in Patients With Moderate to Severe Crohn's Disease：a Prospective Study
Phase N/A · 1 location(s) · The Third Xiangya Hospital of Central South University · NCT07034664A Prospective Observational Study on the Efficacy and Safety of Guselkumab in the Treatment of Crohn's Disease Patients
Phase N/A · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07487480A Study to Evaluate Comparative Efficacy and Safety of Guselkumab in High-dose and Extended-interval Versus Standard-dos
NA · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07532486A Phase 3 Clinical Study of QL2106 Injection
Phase 3 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT07511647A Prospective Cohort Study Evaluating the Efficacy and Safety of Guselkumab (GUS) With JAK Inhibitors in Patients With D
Phase N/A · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07487311Mediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patients Treated With Ant
NA · 1 location(s) · University Hospitals Cleveland Medical Center · NCT06399432Efficacy of Guselkumab in Treating Hailey Hailey Disease
Phase 2 · 1 location(s) · Yale University · NCT06651489COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)
Phase N/A · 4 location(s) · University of North Carolina, Chapel Hill · NCT07198113Potential Role of Guselkumab in Modulating PAIN Perception and Related Gene Pathways: a Proof-of-concept Study.
Phase 4 · 1 location(s) · Fondazione Policlinico Universitario Campus Bio-Medico · NCT06974474A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · 102 location(s) · Janssen Research & Development, LLC · NCT07499232A Real-World Study of Guselkumab in Ulcerative Colitis and Crohn's Disease in Saudi Arabia
Phase N/A · 1 location(s) · Janssen Research & Development, LLC · NCT07541261A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disea
Phase N/A · 1 location(s) · Janssen-Cilag Ltd. · NCT07242248A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD)
Phase 4 · 5 location(s) · Xian-Janssen Pharmaceutical Ltd. · NCT07310095A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)
Phase 4 · 10 location(s) · Johnson & Johnson Private Limited · NCT07141004GUselkumAb inteRvention and DIet evaluAtioN for Pouchitis
Phase 4 · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT06916390A Study to Assess Real-world Outcomes for Long-Term Use of Guselkumab
Phase N/A · 1 location(s) · Janssen-Cilag A.G., Switzerland · NCT07532213Real-Life Evaluation of Guselkumab Dosing Interval Adjustments
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de Nice · NCT07430319A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Phase 3 · 47 location(s) · Janssen Research & Development, LLC · NCT06663332Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG)
Phase 2 · 2 location(s) · Oregon Health and Science University · NCT06563323A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany
Phase N/A · 1 location(s) · Janssen-Cilag G.m.b.H · NCT07102368A Study of Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe Plaque Psoriasis in Romania
Phase N/A · 19 location(s) · Janssen Research & Development, LLC · NCT07582783Immune Spatial Features of Guselkumab Cutaneous Response
Phase 4 · 1 location(s) · University of California, San Francisco · NCT05858632Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy
NA · 1 location(s) · University of California, San Diego · NCT06586281Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics
Phase 4 · 1 location(s) · University Hospitals Cleveland Medical Center · NCT05270733
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.